- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06149065
Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
November 27, 2023 updated by: Mahidol University
The goal of this observational cross-sectional study is to identify factors associated with severity of acne in Thai transmen receiving masculinizing hormone therapy. The main questions it aims to answer are:
- What are the factors associated with severity of acne in transmen?
- Does masculinizing hormone therapy associate with the severity of acne in transmen? Participants will be asked to complete an online questionnaire and allow to take pictures of their face for acne assessment purpose.
Study Overview
Study Type
Observational
Enrollment (Actual)
247
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bangkok
-
Ratchathewi, Bangkok, Thailand, 10400
- Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
All transmen who visited the Gender Variation (GenV) Clinic (outpatient clinic) of Ramathibodi Hospital
Description
Inclusion Criteria:
- Transmen who visited the Gender Variation (GenV) Clinic of Ramathibodi Hospital
- Transmen who received masculinizing hormone therapy (testosterone)
- Transmen who completed an online questionnaire and intentional submit their facial photographs
Exclusion Criteria:
- Refusal to participate
- Incomplete questionnaire
- Missing photos
- Diagnosis of any disorders of sexual differentiation which may have peculiar hormonal effect
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The severity of acne
Time Frame: 1 day (At the time of answering an online questionnaire)
|
Investigator Global Assessment (IGA) scale for acne
|
1 day (At the time of answering an online questionnaire)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2021
Primary Completion (Actual)
June 6, 2023
Study Completion (Actual)
June 6, 2023
Study Registration Dates
First Submitted
November 20, 2023
First Submitted That Met QC Criteria
November 27, 2023
First Posted (Actual)
November 28, 2023
Study Record Updates
Last Update Posted (Actual)
November 28, 2023
Last Update Submitted That Met QC Criteria
November 27, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne
-
CLASSYS Inc.Not yet recruitingAcne Scars | Acne Scarring | Acne Scar | Acne Scars - AtrophicChina
-
ProgenaBiomeWithdrawnAcne Vulgaris | Acne | Acne Rosacea | Acne Inversa | Acne Keloidalis | Acne Keloid | Acne Conglobata | Acne Cystic | Acne Pomade | Acne Indurata | Acne Papular | Acne Tropica | Acne Urticata | Acne Fulminans | Acne Follicular | Acne Tropicalis | Acne Detergicans | Acne Iodide | Acne VarioliformisUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedAcne Scar | Acne Scars - AtrophicChina
-
First Affiliated Hospital of Chongqing Medical...CompletedAcne Scars | Acne ScarringChina
-
Technische Universität DresdenUnknown
-
Elorac, Inc.Completed
-
Chulalongkorn UniversityCompletedPost - Adolescence AcneThailand
-
National Yang Ming UniversityTaipei City HospitalUnknown
-
Seoul National University HospitalCompletedAcne, Photodynamic TherapyKorea, Republic of
-
Cipher Pharmaceuticals Inc.CompletedSevere Nodular AcneUnited States, Canada
Clinical Trials on Testosterone
-
Sports Medicine Research and Testing LaboratoryCompleted
-
University of VermontSuspendedBreast Neoplasms | Vaginitis | DyspareuniaUnited States
-
University of MiamiNot yet recruitingProstate Cancer | Hypogonadism, MaleUnited States
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedHypogonadism | Growth Hormone Deficiency | HypopituitarismUnited States
-
Leonard S. Marks, M.D.Watson Pharmaceuticals; Solvay PharmaceuticalsCompletedMen With Low Testosterone LevelsUnited States
-
Charles Drew University of Medicine and ScienceCompletedStress Urinary IncontinenceUnited States
-
University of MiamiAcerus Pharmaceuticals CorporationCompletedHypogonadism, MaleUnited States
-
Clarus Therapeutics, Inc.Completed
-
University of Sao Paulo General HospitalCompleted
-
University Hospital MuensterCompleted